Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Vaxil Bio Ltd.
  6. News
  7. All News
    VXL   CA92243L1076

VAXIL BIO LTD.

(VXL)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about VAXIL BIO LTD.
08/30Vaxil Bio Ltd. Reports Earnings Results for the Second Quarter Ended June 30,..
CI
08/04VAXIL BIO : Names Avnir as Interim Chief Executive as Goren Departs
MT
08/04Vaxil Bio Ltd. Appoints Yuval Avnir as Interim Chief Executive Officer
CI
08/04VAXIL BIO : Announces Changes to Senior Management and Provides Updates on Curre..
AQ
08/04Vaxil Bio Ltd. Announces Executive Changes
CI
05/31Vaxil Bio Ltd. Reports Earnings Results for the First Quarter Ended March 31,..
CI
05/31UPDATE : Vaxil Down Near 5% as Provides Research and Development Update
MT
05/31VAXIL BIO : Provides Research and Development Update
AQ
05/05VAXIL BIO : Announces CEO Resignation
AQ
05/05David Goren Resigns as Chief Executive Officer of Vaxil Bio Ltd
CI
04/29Vaxil Bio Ltd. Reports Earnings Results for the Full Year Ended December 31, ..
CI
04/29Vaxil Bio Ltd. Auditor Raises 'Going Concern' Doubt
CI
04/19VAXIL BIO LTD.(TSXV : VXL) dropped from S&P/TSX Venture Composite Index
CI
03/11VAXIL BIO : Announces 2021 research and development strategy and progress
PU
03/11VAXIL BIO : Outlines 2021 Research Goals; Working on Covid-19 Vaccine
MT
03/11Vaxil Bio Ltd. Announces 2021 Reseach and Development Strategy and Progress
CI
03/11VAXIL BIO : Announces 2021 Reseach and Development Strategy and Progress
AQ
02/17UPDATE : Vaxil Bio Plunges 65% as Provides Update on COVID-19 Challenge Study
MT
02/17VAXIL BIO : Down 10% as Provides Update on COVID-19 Challenge Study
MT
02/17VAXIL BIO : IIROC Trading Resumption - VXL
AQ
02/17VAXIL BIO : Provides Strategy Update From Conclusion of COVID-19 Challenge Study
AQ
02/17Vaxil Bio Ltd. Provides Strategy Update from Conclusion of Covid-19 Challenge..
CI
02/17VAXIL BIO : IIROC Trading Halt - VXL
AQ
02/01VAXIL BIO LTD. Appoints Michael Berelowitz as Special Advisor to its Board
CI
02/01VAXIL BIO : Appoints a Special Advisor to the Board of Directors
AQ
01/28VAXIL BIO : Provides Update on USAMRIID Oral Experiment and Other General Busine..
AQ
01/27VAXIL BIO : Provides Update on USAMRIID, Oral Experiment and Other General Busin..
AQ
01/18VAXIL BIO LTD.(TSXV : VXL) added to S&P/TSX Venture Composite Index
CI
2020VAXIL BIO : Annual and Special Shareholders Meeting and Update on Exercise of Wa..
AQ
2020VAXIL BIO : Gained 15% Today, Then Provides Update on USAMRIID and Oral Experime..
MT
2020VAXIL BIO : Provides Update on USAMRIID and Oral Experiments
AQ
2020VAXIL BIO LTD. Provides Update on USAMRIID and Oral Experiments
CI
2020VAXIL BIO : Retains Investor Engagement and Marketing Firm
AQ
2020VAXIL BIO : Announces Close of Second and Final Tranche of Previously Announced ..
AQ
2020Vaxil Bio Ltd. announced that it has received CAD 0.806958 million in funding
CI
2020VAXIL BIO : Nearly 18% Higher as Provides Business Update on Corvax Experiments
MT
2020VAXIL BIO : Provides Business Update on Corvax™ Experiments
AQ
2020Vaxil Bio Ltd. Provides Business Update on Corvax Experiments
CI
2020Vaxil Bio Ltd. Reports Earnings Results for the Third Quarter Ended September..
CI
2020VAXIL BIO : Announces Close of First Tranche of Previously Announced NonBrokered..
AQ
2020VAXIL BIO : Announces Close of First Tranche of Previously Announced Non-Brokere..
AQ
2020VAXIL BIO : Announces Non-Brokered Private Placement
AQ
2020VAXIL BIO : IIROC Trading Resumption - VXL
AQ
2020VAXIL BIO : IIROC Trading Halt - VXL
AQ
2020Vaxil Bio Ltd. announced that it expects to receive CAD 1.5 million in fundin..
CI
2020VAXIL BIO : IIROC Trading Resumption - VXL
AQ
2020VAXIL BIO : Enters Into a Cooperative Research and Development Agreement With U...
AQ
2020VAXIL BIO : IIROC Trading Halt - VXL
AQ
2020Vaxil Enters into a Cooperative Research and Development Agreement with U.S. ..
CI
2020VAXIL BIO : Initiates Pre-Clinical Study in New Oncology Target
AQ
2020Vaxil Bio Ltd. Initiates Pre-Clinical Study in New Oncology Target
CI
2020VAXIL BIO : Provides Update of Conversion of Previously Issued Convertible Debt ..
AQ
2020VAXIL BIO : Announces Positive Results on CorVax™ in vivo Study
AQ
2020Vaxil Bio Ltd. Announces Positive Results on CorvaxÖ in Vivo Study
CI
2020Vaxil Bio Ltd. Reports Earnings Results for the Second Quarter Ended June 30,..
CI
2020VAXIL BIO : Provides Update on In Vivo Study
AQ
2020Vaxil Bio Ltd. Provides Update on In Vivo Study
CI
2020VAXIL BIO : Cancels Brokered Private Placement
AQ
2020Vaxil Bio Ltd. cancelled the transaction announced on May 26, 2020
CI
2020Vaxil Bio Ltd. Provides an Update on Covid-19 Vaccine Candidate
CI
2020VAXIL BIO : Provides Pre-Clinical and Business Update
AQ
2020VAXIL BIO LTD.(TSXV : VXL) dropped from S&P/TSX Venture Composite Index
CI
2020VAXIL BIO : Announces Private Placement Extension
AQ
2020VAXIL BIO : Announces Brokered Private Placement
AQ
2020Vaxil Bio Ltd. announced that it expects to receive CAD 3 million in funding
CI
2020Vaxil Announces Collaboration Agreement with the Tel Aviv Sourasky Medical Ce..
CI
2020VAXIL BIO : Announces Collaboration Agreement With The Tel Aviv Sourasky Medical..
AQ
2020VAXIL BIO : Announces Audited Annual Results and Provides Business Update
AQ
2020Vaxil Bio Ltd. Reports Earnings Results for the Full Year Ended December 31, ..
CI
2020Vaxil Bio Ltd. Auditor Raises 'Going Concern' Doubt
CI
2020VAXIL BIO LTD.(TSXV : VXL) added to S&P/TSX Venture Composite Index
CI
2020Vaxil Bio Ltd. Shares the Results of First Preclinical Experiment to Test the..
CI
2020CORRECTION : Vaxil provides update on preclinical experiment
AQ
2020VAXIL BIO : Provides Update on Preclinical Experiment
AQ
2020VAXIL BIO : Commences preclinical covid-19 vaccine trial and files an additional..
AQ
1  2Next
Upcoming event on VAXIL BIO LTD.